Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease

CONCLUSIONS: Comorbidities affect the hypothesized biomarkers as diabetes progresses. Mitochondrial oxidative stress indicators, coagulation, and inflammatory markers help assess diabetes disease development and provide appropriate medications. Future studies will examine longitudinal biomarker evolution.PMID:38707193 | PMC:PMC11069335 | DOI:10.1177/11772719231222111

Source: Biomarker Insights - May 6, 2024 Category: General Medicine Authors: Symeon Savvopoulos Haralampos Hatzikirou Herbert F Jelinek Source Type: research